Skip to main content

Table 4 Baseline and Follow-up Pathology Data for patients reviewed in the 12-week post hospitilisation COVID-19 virtual clinic

From: Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19

Variable Baseline Pathology Results 12-week Pathology Results
n Complete Resolution Persistent Abnormality p value n Complete Resolution Persistent Abnormality p value
Hb (g/L) 98 132 (118–143) 136 (126–146) 0.159 97 140 (131–147) 140 (124–147) 0.793
WBC (10 × 9/L) 98 6.7 (5.0–8.3) 6.8 (4.6–11.4) 0.616 97 7.0 (4.5–6.6) 7.3 (6.1–9.3) 0.190
Neutrophils (10 × 9/L) 98 4.8 (3.6–6.3) 5.7 (3.7–8.8) 0.296 97 3.7 (2.6–4.4) 4.0 (3.1–5.2) 0.164
Lymphocytes (10 × 9/L) 98 1.0 (0.8–1.2) 1.0 (0.7–1.5) 0.882 97 2.0 (1.6–2.7) 2.4 (1.8–3.0) 0.163
Sodium (mmol/L) 96 137 (135–140) 135 (133–138) 0.007** 97 140 (139–142) 141 (139–142) 0.752
Urea (mmol/L) 96 4.8 (3.6–6.2) 6.4 (4.9–7.8) 0.033* 96 5.5 (4.5–6.6) 5.9 (4.5–7.2) 0.402
Creatinine (μmol/L) 96 69.5 (57.0–89.8) 73.5 (60.0–91.5) 0.724 96 74 (62–89) 68 (56–81) 0.206
Ferritin (μg/L) 80 539 (285–1417) 752 (452–1121) 0.385 50 41 (26–82) 41 (29–107) 0.807
LDH (U/L) 73 679 (502–955) 957 (697–1193) 0.006** 48 373 (317–405) 435 (360–490) 0.004**
CRP (mg/L) 96 94 (32–150) 115 (86–155) 0.123 97 2 (1–4) 3 (1–6) 0.333
HS-Troponin I (ng/L) 76 7 (4–12) 11 (6–27) 0.014* 48 3 (2–5) 3 (3–5) 0.365
ALT (U/L) 89 32 (22–63) 36 (25–65) 0.510 96 22 (18–31) 21 (13–41) 0.710
Bilirubin (μmol/L) 77 9 (7–12) 13 (8–18) 0.015* 96 9 (7–11) 8 (7–12) 0.984
D-dimer (μg/L) 59 447 (295–811) 548 (407–734) 0.257 85 < 230& < 230& 0.769
  1. Hb haemoglobin, WBC total white blood cell count, LDH lactate dehydrogenase, CRP C-Reactive protein, HS-Troponin I-High Sensitivity Troponin I, ALT alanine transaminase
  2. *p < 0.05
  3. **p < 0.01
  4. &230 μg/L lower limit of d-dimer detection